Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
In this review, we focus on the secreted form of nicotinamide phosphoribosyltransferase (NAMPT); extracellular NAMPT (eNAMPT), also known as pre‐B cell colony‐enhancing factor or visfatin. Although intracellular NAMPT is a key enzyme in controlling NAD metabolism, eNAMPT has been reported to function as a cytokine, with many roles in physiology and pathology. Circulating eNAMPT has been associated with several metabolic and inflammatory disorders, including cancer. Because cytokines produced in the tumour micro‐environment play an important role in cancer pathogenesis, in part by reprogramming cellular metabolism, future improvements in cancer immunotherapy will require a better understanding of the crosstalk between cytokine action and tumour biology. In this review, the knowledge of eNAMPT in cancer will be discussed, focusing on its immunometabolic function as a metabokine, its secretion, its mechanism of action and possible roles in the cancer micro‐environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedFukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
RetractedThe BioPlex network: a systematic exploration of the human interactome
Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.043 · Cited by 1,425 · cited 2×
“…of molecular screening studies (e.g. two-hybrid assays, af fi nity capture and co-fractionation) have identi fi ed eNAMPT as a putative protein-binding partner (Zhang et al. , 2008; Perez-Hernandez et al. , 2013; Huttlin et al. , 2015; Wan et al. , 2015), although these also remain to be validated.”
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 4×
“Indeed, most reports suggest that its release is insensitive to brefeldin-A and monensin, that is, inhibitors of the classical ER – Golgi-dependent pathway (Revollo et al. , 2007; Tanaka et al. , 2007; Garten et al. , 2010).”
InfluentialCurat, C. A., Wegner, V., Sengenès, C., Miranville, A., Tonus, C., Busse, R., & Bouloumié, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0173-z · Cited by 693
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Sampath, D., Zabka, T. S., Misner, D. L., O’Brien, T., & Dragovich, P. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.02.004 · Cited by 258
The release of the adipocytokine visfatin is regulated by glucose and insulin
Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0303-7 · Cited by 258
Watson, M., Roulston, A., Bélec, L., Billot, X., Marcellus, R., Bédard, D., Bernier, C., Branchaud, S., Chan, H., Dairi, K., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00112-09 · Cited by 229
Camp, S. M., Ceco, E., Evenoski, C. L., Danilov, S. M., Zhou, T., Chiang, E. T., Moreno-Vinasco, L., Mapes, B., Zhao, J., Gursoy, G., et al. (2015) · Scientific Reports · doi:10.1038/srep13135 · Cited by 180
Hara, N., Yamada, K., Shibata, T., Osago, H., & Tsuchiya, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022781 · Cited by 116
Pillai, V. B., Sundaresan, N. R., Kim, G., Samant, S., Moreno-Vinasco, L., Garcia, J. G. N., & Gupta, M. P. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00468.2012 · Cited by 97 · cited 7×
“(Pillai et al. , 2013).”
InfluentialSebocytes differentially express and secrete adipokines
Kovács, D., Lovászi, M., Póliska, S., Oláh, A., Bíró, T., Veres, I., Zouboulis, C. C., Ståhle, M., Rühl, R., Remenyik, É., et al. (2016) · Experimental Dermatology · doi:10.1111/exd.12879 · Cited by 76
Chan, M., Gravel, M., Bramoullé, A., Bridon, G., Avizonis, D., Shore, G. C., & Roulston, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0809 · Cited by 46 · cited 1×
“The link between iNAMPT and cancer is well documented (Garten et al. , 2009; Galli et al. , 2010; Burgos, 2011; Sampath et al. , 2015); indeed, it is essential for restoration of the NAD pool following over activation of PARPs and SIRTs, in cancer cells (Wang et al. , 2011; Chan et al. , 2014).”
Van den Bergh, R., Morin, S., Sass, H. J., Grzesiek, S., Vekemans, M., Florence, E., Thanh Thi Tran, H., Imiru, R. G., Heyndrickx, L., Vanham, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035074 · Cited by 40 · cited 1×
“In 2012, eNAMPT was reported to selectively inhibit infection of macrophages by HIV and this activity was linked, using surface plasmon resonance, to a direct interaction with the chemokine receptor CCR5 (Van den Bergh et al. , 2012).”
Cited by
Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine
Nimptsch, K., Konigorski, S., & Pischon, T. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.006 · Cited by 314
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Lv, H., Lv, G., Chen, C., Zong, Q., Jiang, G., Ye, D., Cui, X., He, Y., Xiang, W., Han, Q., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.021 · Cited by 301
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
Galli, U., Colombo, G., Travelli, C., Tron, G. C., Genazzani, A. A., & Grolla, A. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00656 · Cited by 162
Self-citationMateuszuk, Ł., Campagna, R., Kutryb-Zając, B., Kuś, K., Słominska, E. M., Smolenski, R. T., & Chlopicki, S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114019 · Cited by 81
Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
Navas, L. E., & Carnero, A. (2022) · Cells · doi:10.3390/cells11172627 · Cited by 68
Metadata
- Authors
- Grolla, A. A., Travelli, C., Genazzani, A. A., & Sethi, J. K.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2016-06-02
- Volume
- 173
- Issue
- 14
- Pages
- 2182-2194
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2343462384
- Cited by
- 115
- References
- 14
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.